Deep intronic variants introduce DMD pseudoexon in patient with muscular dystrophy
- 1 July 2017
- journal article
- case report
- Published by Elsevier in Neuromuscular Disorders
- Vol. 27 (7) , 631-634
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Genetic diagnosis of Duchenne/Becker muscular dystrophy using next-generation sequencing: validation analysis of DMD mutationsJournal of Human Genetics, 2016
- RNA seq analysis for the diagnosis of muscular dystrophyAnnals of Clinical and Translational Neurology, 2015
- Pseudoexon activation increases phenotype severity in a Becker muscular dystrophy patientMolecular Genetics & Genomic Medicine, 2015
- Evidence‐based path to newborn screening for duchenne muscular dystrophyAnnals of Neurology, 2012
- Pure intronic rearrangements leading to aberrant pseudoexon inclusion in dystrophinopathy: a new class of mutations?Human Mutation, 2011
- Mutational spectrum of DMD mutations in dystrophinopathy patients: application of modern diagnostic techniques to a large cohortHuman Mutation, 2009
- DMD pseudoexon mutations: splicing efficiency, phenotype, and potential therapyAnnals of Neurology, 2007
- Improved molecular diagnosis of dystrophinopathies in an unselected clinical cohortAmerican Journal of Medical Genetics Part A, 2005
- Three‐tiered noninvasive diagnosis in 96% of patients with Duchenne muscular dystrophy (DMD)Human Mutation, 2004
- Newly recognized exons induced by a splicing abnormality from an intronic mutation of the dystrophin gene resulting in Duchenne muscular dystrophyHuman Mutation, 1999